ASCO Annual Meeting |

ASCO Annual Meeting |

NCI at ASCO 2018

Sunday, June 3

Today is the third day of the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting and we hope you join us in attending NCI Deputy Director Dr. Lowy’s lecture on HPV vaccination this afternoon.

If you want to engage with NCI at the conference, you can attend the NCI-featured sessions listed below, or stop by the NCI Exhibit Booth (#5041) for a “Meet the Experts” session, free publications, and more!

For more information about NCI activities at ASCO, visit the NCI at ASCO 2018 webpage.

NCI Director's Remarks

HAPPENING TODAY!  Join NCI Deputy Director Douglas R. Lowy, M.D., recipient of the 2018 ASCO Science of Oncology Award, for his lecture on Preventing HPV-Associated Cancers by Vaccination this afternoon. Sunday, June 31:10 PM – 1:40 PMHall B1 NCI Speakers and Sessions at ASCO (Sunday) Targeted resequencing of pediatric rhabdomyosarcoma: Report from the Children’s Oncology Group, the Children’s Cancer and Leukaemia Group, The Institute of Cancer Research UK, and the National Cancer Institute  John Frederick Shern, M.D. 10:00 AM - 10:12 AM  At the "Pediatric Oncology II" oral abstract session, Dr. Shern will present an abstract on the largest genomic characterization of clinically annotated patients with Rhabdomyosarcoma (RMS) tumors to date. Germline Genomics and the Risk of Developing Treatment-Related Subsequent Neoplasms   Lindsay M. Morton, Ph.D. 11:30 AM - 11:50 AM Join Dr. Morton to learn how germline genomics can play a role in identifying survivors at risk for adverse effects of cancer treatment during the “How Can Genetics Personalize Cancer Survivorship” education session. NCI-SEER Now and Into the Future as a Partner in Real-World Evidence Generation  Lynne Penberthy, M.D. 11:45 AM - 12:00 PM Jump into the NCI’s Surveillance, Epidemiology, and End Results (SEER) program with Dr. Penberthy, and learn how this database is enhancing the real-world evidence ecosystem. Rational Approach to Utilizing Genetic Information  Elise Kohn, M.D. 12:10 PM - 12:30 PM In the “Moving from Mutation to Actionability” education session, Dr. Kohn will speak about utilizing genetic information through a rational approach. Preventing HPV-Associated Cancers by Vaccination Douglas R. Lowy, M.D. 1:10 PM - 1:40 PM Join NCI Deputy Director Douglas R. Lowy, M.D., recipient of the 2018 ASCO Science of Oncology Award, for his Plenary Session lecture on Preventing HPV-Associated Cancers by Vaccination.  TAILORx: Phase III trial of chemoendocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, node-negative breast cancer and an intermediate prognosis 21-gene recurrence score  Joseph A. Sparano, M.D. - Montefiore Medical Center 1:45 PM - 2:00 PM Dr. Sparano will share recent results from the TAILORx trial during the 2018 Plenary Session. The Trial Assigning Individualized Options for Treatment (Rx), or TAILORx, is examining whether genes that are frequently associated with risk of recurrence for women with early-stage breast cancer can be used to assign patients to the most appropriate and effective treatment. For more information about this NCI-sponsored trial, visit the TAILORxwebpage. Immunotherapy in Prostate Cancer: The Path Forward  Ravi Amrit Madan, M.D. 5:25 PM - 5:45 PM In the “Winds of Change” education session, Dr. Ravi Madan will discuss past successes and future directions in immunotherapy approaches to inform prostate cancer treatment selection. Activities at the NCI Exhibit Booth (#5041) Want to learn more about what's happening across the National Cancer Institute? Attend a "Meet the Experts" session! Check out the Sunday "Meet the Experts" schedule on the NCI at ASCO 2018 webpage. We look forward to seeing you at the booth!